You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 759 ADPORT-601 (TT-10–101): first-in-human study of adenosine 2A (A2A) and adenosine 2B (A2B) receptor antagonists in participants with selected advanced solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
759 ADPORT-601 (TT-10–101): first-in-human study of adenosine 2A (A2A) and adenosine 2B (A2B) receptor antagonists in participants with selected advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 2023200016
Dec 202360010
Jan 20244504
Feb 20245001
Mar 20244405
Apr 202446010
May 20243001
Jun 20242903
Jul 20242802
Aug 20246203
Sep 20244805
Total642060